These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1115 related items for PubMed ID: 10091096

  • 21. Helicobacter pylori and impaired gastric secretory functions associated with duodenal ulcer and atrophic gastritis.
    Konturek PC, Konturek SJ, Bobrzyński A, Kwiecień N, Obtułowicz W, Stachura J, Hahn EG, Rembiarz K.
    J Physiol Pharmacol; 1997 Sep; 48(3):365-73. PubMed ID: 9376619
    [Abstract] [Full Text] [Related]

  • 22. [Time course changes in morphological and functional characteristics of gastric mucosa after eradication of Helicobacter pylori in duodenal ulcers].
    Pimanov SI, Makarenko EV, Voropaeva AV, Matveenko ME.
    Ter Arkh; 2006 Sep; 78(2):26-31. PubMed ID: 16613092
    [Abstract] [Full Text] [Related]

  • 23. Recovery after Helicobacter pylori eradication: how long does it take?
    Correa P.
    Ital J Gastroenterol Hepatol; 1999 Sep; 31(1):9. PubMed ID: 10091097
    [No Abstract] [Full Text] [Related]

  • 24. Regional differences in the recovery of gastric acid secretion after Helicobacter pylori eradication: evaluations with Congo red chromoendoscopy.
    Sekine H, Iijima K, Koike T, Abe Y, Imatani A, Kato K, Ohara S, Shimosegawa T.
    Gastrointest Endosc; 2006 Nov; 64(5):678-85. PubMed ID: 17055856
    [Abstract] [Full Text] [Related]

  • 25. Evaluation of the effects of Helicobacter pylori eradication therapy on gastric antral epithelial hyperproliferation: a prospective six-month follow-up study.
    Demiray M, Gulten M, Manavoglu O, Evrensel T, Ulukaya E, Yerci O, Kanat O, Kurt E, Arslan M, Gonullu G, Demiray H, Gulten T, Memik F.
    Hepatogastroenterology; 2004 Nov; 51(59):1531-5. PubMed ID: 15362794
    [Abstract] [Full Text] [Related]

  • 26. Effects of Helicobacter pylori on gastritis, pentagastrin-stimulated gastric acid secretion, and meal-stimulated plasma gastrin release in the absence of peptic ulcer disease.
    Hurlimann S, Dür S, Schwab P, Varga L, Mazzucchelli L, Brand R, Halter F.
    Am J Gastroenterol; 1998 Aug; 93(8):1277-85. PubMed ID: 9707051
    [Abstract] [Full Text] [Related]

  • 27. Eradication rate of Helicobacter pylori in a Mexican population at high risk for gastric cancer and use of serology to assess cure.
    Mohar A, Ley C, Guarner J, Herrera-Goepfert R, Figueroa LS, Halperin D, Parsonnet J.
    Am J Gastroenterol; 2002 Oct; 97(10):2530-5. PubMed ID: 12385434
    [Abstract] [Full Text] [Related]

  • 28. The efficacy of two-week therapy with ranitidine bismuth citrate, amoxicillin and clarithromycin on Helicobacter pylori eradication in clarithromycinresistant and- sensitive cases.
    Aydin A, Onder GF, Akarca US, Tekin F, Tunçyürek M, Musoğlu A.
    Turk J Gastroenterol; 2005 Dec; 16(4):203-6. PubMed ID: 16547848
    [Abstract] [Full Text] [Related]

  • 29. Triple eradication therapy counteracts functional impairment associated with Helicobacter pylori infection in Mongolian gerbils.
    Brzozowski T, Konturek PC, Kwiecien S, Konturek SJ, Pajdo R, Drozdowicz D, Ptak A, Pawlik M, Stachura J, Pawlik WW, Hahn EG.
    J Physiol Pharmacol; 2003 Mar; 54(1):33-51. PubMed ID: 12674217
    [Abstract] [Full Text] [Related]

  • 30. Screening of atrophic gastritis and gastric cancer by serum pepsinogen, gastrin-17 and Helicobacter pylori immunoglobulin G antibodies.
    Cao Q, Ran ZH, Xiao SD.
    J Dig Dis; 2007 Feb; 8(1):15-22. PubMed ID: 17261130
    [Abstract] [Full Text] [Related]

  • 31. Is there any relationship between functional dyspepsia and chronic gastritis associated with Helicobacter pylori infection?
    Kyzekové J, Arlt J, Arltová M.
    Hepatogastroenterology; 2001 Feb; 48(38):594-602. PubMed ID: 11379362
    [Abstract] [Full Text] [Related]

  • 32. Implications of corpus gastritis, atrophy and cyclooxygenase in the development of gastric erosions after curing Helicobacter pylori infection.
    Miyake K, Tatsuguchi A, Suzuki K, Ueki N, Shinji Y, Kusunoki M, Iizumi T, Hiratsuka T, Nishigaki H, Futagami S, Wada K, Tsukui T, Sakamoto C.
    Dig Liver Dis; 2005 Jun; 37(6):394-401. PubMed ID: 15893277
    [Abstract] [Full Text] [Related]

  • 33. Helicobacter pylori eradication decreases the expression of glycosylphosphatidylinositol-anchored complement regulators, decay-accelerating factor and homologous restriction factor 20, in human gastric epithelium.
    Joh T, Sasaki M, Kataoka H, Tanida S, Itoh K, Kondo Y, Ogasawara N, Oshima T, Okada N, Ohara H, Sano H, Nakao H, Sobue S, Itoh M.
    J Gastroenterol Hepatol; 2005 Sep; 20(9):1344-51. PubMed ID: 16105119
    [Abstract] [Full Text] [Related]

  • 34. Increase in apoptosis and decrease in ornithine decarboxylase activity of the gastric mucosa in patients with atrophic gastritis and gastric ulcer after successful eradication of Helicobacter pylori.
    Hirasawa R, Tatsuta M, Iishi H, Yano H, Baba M, Uedo N, Sakai N.
    Am J Gastroenterol; 1999 Sep; 94(9):2398-402. PubMed ID: 10483998
    [Abstract] [Full Text] [Related]

  • 35. Effect of Helicobacter pylori infection on gastric acid secretion and meal-stimulated serum gastrin in children.
    Kato S, Ozawa K, Koike T, Sekine H, Ohara S, Minoura T, Iinuma K.
    Helicobacter; 2004 Apr; 9(2):100-5. PubMed ID: 15068410
    [Abstract] [Full Text] [Related]

  • 36. Effect of eradication of Helicobacter pylori on serum pepsinogen I, gastrin, and insulin in duodenal ulcer patients: a 12-month follow-up study.
    Chen TS, Tsay SH, Chang FY, Lee SD.
    Am J Gastroenterol; 1994 Sep; 89(9):1511-4. PubMed ID: 8079929
    [Abstract] [Full Text] [Related]

  • 37. Long-term strict monitoring of plasma ghrelin and other serological markers of gastric diseases after Helicobacter pylori eradication.
    Masaoka T, Suzuki H, Imaeda H, Hosoda H, Ohara T, Morishita T, Ishii H, Kangawa K, Hibi T.
    Hepatogastroenterology; 2005 Sep; 52(61):1-4. PubMed ID: 15782980
    [Abstract] [Full Text] [Related]

  • 38. Plasma ghrelin concentration correlates with the levels of serum pepsinogen I and pepsinogen I/II ratio--a possible novel and non-invasive marker for gastric atrophy.
    Suzuki H, Masaoka T, Hosoda H, Nomura S, Ohara T, Kangawa K, Ishii H, Hibi T.
    Hepatogastroenterology; 2004 Sep; 51(59):1249-54. PubMed ID: 15362725
    [Abstract] [Full Text] [Related]

  • 39. Apparent reversal of early gastric mucosal atrophy after triple therapy for Helicobacter pylori.
    Borody TJ, Andrews P, Jankiewicz E, Ferch N, Carroll M.
    Am J Gastroenterol; 1993 Aug; 88(8):1266-8. PubMed ID: 8338096
    [Abstract] [Full Text] [Related]

  • 40. Can lansoprazole, amoxicillin, and clarithromycin combination still be used as a first-line therapy for eradication of helicobacter pylori?
    Güliter S, Keleş H, Ozkurt ZN, Cengiz DU, Kolukisa E.
    Turk J Gastroenterol; 2005 Mar; 16(1):29-33. PubMed ID: 16252185
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 56.